A grant from the Rosenau Family Research Foundation will examine how an enzyme deficiency in the brain leads to this fatal ...
Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...
Pheno Therapeutics Limited has received clinical trial authorisation (CTA) from the UK’s MHRA for its lead candidate, PTD802.
Dianthus Therapeutics is advancing treatments for autoimmune diseases. Read why DNTH stock is receiving Buy ratings and price ...
It only took six minutes during Thursday night’s Trigg County Schools Board of Education meeting. But in the end, a trio of ...
The American Academy of Neurology announces today its newest journal, Neurology® Open Access, which joins the flagship journal Neurology® and its four subspecialty journals. The new online ...
News Medical on MSN10d
Pheno Therapeutics receives clinical trial authorization for novel multiple sclerosis therapeuticPheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...
Atomi Financial Group Inc. bought a new stake in argenx SE (NASDAQ:ARGX – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange ...
GlobalData on MSN11d
Pheno Therapeutics gains UK MHRA’s CTA for multiple sclerosis therapy trialDeveloped under an exclusive worldwide licence agreement with UCB, PTD802 is designed to counteract the effects of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback